<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://vitalspanwire.com/news/fda-glutathione-injections-supplement-grade-endotoxin-alert</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-29T21:01:59.407Z</news:publication_date><news:title>FDA links intravenous glutathione reactions to supplement-grade ingredient</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/atorvastatin-staree-cardiovascular-events-disability</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-29T16:02:54.415Z</news:publication_date><news:title>Atorvastatin reduced cardiovascular events but not disability in STAREE trial</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/palbociclib-cyclin-d1-cdk6-aged-mice</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-29T11:03:30.713Z</news:publication_date><news:title>Palbociclib reduced senescence-linked inflammation and frailty in aged mice</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/slte-1009-pacap-vip-antibody-phase-1-migraine</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-28T21:02:11.284Z</news:publication_date><news:title>Slate begins first-in-human test of dual PACAP/VIP antibody for migraine</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/aficamten-nonobstructive-hcm-phase-3</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-28T16:02:47.012Z</news:publication_date><news:title>Aficamten improved function in nonobstructive HCM, with cardiac safety trade-offs</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/centenarian-parentage-delayed-hypertension-cohorts</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-28T11:02:34.152Z</news:publication_date><news:title>Centenarian parentage tracks with delayed hypertension across three cohorts</news:title></news:news></url></urlset>